BCAL Diagnostics Limited (ASX:BDX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0650
-0.0010 (-1.52%)
Aug 7, 2026, 2:49 PM AEST

BCAL Diagnostics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
2.542.653.052.790.720.28
Revenue Growth
-4.25%-13.01%9.18%288.29%161.09%-37.74%
Gross Profit
2.542.653.052.790.720.28
Operating Income
-6.92-7.04-6.08-4.79-3.05-0.93
Net Income
-7.16-7.24-6.4-5.06-3.39-1.52
Earnings Per Share
-0.02-0.02-0.03-0.02-0.02-0.01
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
3.334.526.473.179.573.41
Total Debt
3.442.381.521.06--
Net Cash (Debt)
-0.112.144.952.119.573.41
Net Cash Growth
--56.68%134.25%-77.93%180.88%2831.95%
Net Cash Per Share
-0.000.010.020.010.050.03

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-5.96-6.14-4.52-6.05-3.22-1.21
Capital Expenditures
-0.5-0.79-1.15-0.36-0.03-0
Free Cash Flow
-6.46-6.92-5.67-6.41-3.25-1.21
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-272.60%-265.55%-199.51%-171.55%-424.13%-339.30%
Pretax Margin
-281.26%-273.21%-210.07%-181.39%-471.08%-554.03%
Profit Margin
-282.10%-273.21%-210.07%-181.39%-471.08%-554.03%
FCF Margin
-254.48%-261.23%-186.23%-229.72%-451.54%-439.70%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
9.448.7012.905.3323.09-